or nebulization (7%), or ipratropium bromide in a fixed-dose combination with albuterol (38%). Overall, exposure to anticholinergics was associated with a 29% higher risk of CVEs relative to no ...

Objectives Continuous albuterol nebulization is generally administered at 2.5–20 mg/hr at most centers. We examined the effect of high-dose (75 or 150 mg/hr) albuterol on clinical variables in ...